HIMS Misunderstood Opportunity with Massive Upside

3 months ago

"I've owned HIMS from $7 per share. I have averaged up multiple times on the company and I've been talking about it on YouTube from around $10 per share and I always get a lot of dislikes when I talk about this one because I really believe it's a misunderstood opportunity in general especially right now as a company is going through a transition period which is why I think it's presenting an amazing opportunity. The company is diversifying away from weight loss and expanding into sexual health, dermatology, mental health, hormone health and longevity, which I believe will drive a massive multiple expansion to at least six times sales or seven times sales, potentially even 10 times sales. With a current market cap of $10 billion and a forecast of a 225% to 550% upside over the next 4-5 years, this is one of the best risk-rewards in the market."

The speaker presents HIMS as a misunderstood growth opportunity undergoing a transition from solely weight loss to more diversified healthcare offerings, positioning it for significant multiple expansion and substantial upside (225%-550%) over the next 4-5 years.

Related Stocks